Table 2.
Atypical ductal hyperplasia (ADH) and ipsilateral breast tumor recurrence (IBTR).
| Investigator | no. BCS specimens | no. lumpectomy + for ADH | IBTR ADH (+) no. (%) | IBTR in ADH (−) no. (%) | Median Followup (years) |
|---|---|---|---|---|---|
| Goldstein et al. [33] | 94 | 54 | 3/54 (5.6)′ | 0/36 (0)′′ | 6.5 |
| Fowble et al. [34] | 460 | 99† | 1/99 (1.0) | 17/329 (5.2) | 4.8 |
| Greene et al. [35] | 155* | 87 | 0/87 (0%)** | 1/68 (1.5)** | 2.2 |
′ADH (+) at margin more recurrence than ADH (−) at margin P < 0.01.
′′Represents lesions negative for both ADH and COL.
†ADH involved somewhere in specimen, not specifically involving margin.
*Lumpectomy performed for ADH, no malignancy in original specimen.
**denotes malignancy development and not recurrence as initial lumpectomy was negative for malignancy.